One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a ...

A new study found that people who use semaglutide are not at risk for developing suicidal thoughts or behavior. As the debate ...

One of the most striking shifts has been in the area of bariatric surgery, where once-steady demand for weight-loss ...

Just like its sister medication, Ozempic, Wegovy has been linked to lower risks of cardiovascular disease and other causes of ...

For patients on a 12-month plan, Hims offers a semaglutide injection for $199 a month. Ozempic and Wegovy carry high list prices of $935.77 and $1,349.02, respectively, for a month’s supply, according ...

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn’t ...

These drugs work to treat diabetes and weight loss by suppressing the appetite and lowering blood sugar and A1C—which may end ...

A new study found that people taking Wegovy during the pandemic were 33 percent less likely to die of COVID-19.

A SELECT trial subanalysis showed that semaglutide works as well in people with CVD, overweight/obesity, and impaired kidney ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...